We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
(+14%)
Cap. Flow
+$7.27B
Cap. Flow
% of AUM
9.7%
Top 10 Holdings %
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.04B |
| 2 |
Microsoft
MSFT
|
+$830M |
| 3 |
Amazon
AMZN
|
+$550M |
| 4 |
Johnson & Johnson
JNJ
|
+$483M |
| 5 |
Apple
AAPL
|
+$470M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$474M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$435M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$428M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$371M |
| 5 |
Micron Technology
MU
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Consumer Discretionary | 13.75% |
| 3 | Healthcare | 12.4% |
| 4 | Financials | 7.81% |
| 5 | Industrials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUROW
1776
CALL
Aurora Innovation Warrant
AUROW
$328M
| $750K | ﹤0.01% |
270,811
-72,108
| -21% | -$16.3K |
|
1777
SharkNinja
SN
$22.4B
| $749K | ﹤0.01% |
9,969
-5,560
| -36% | -$392K |
|
1778
Starwood Property Trust
STWD
$6.19B
| $748K | ﹤0.01% |
39,467
+24,357
| +161% | +$475K |
|
1779
iShares MSCI Netherlands ETF
EWN
$558M
| $744K | ﹤0.01% |
14,806
+7,284
| +97% | +$365K |
|
1780
Minerals Technologies
MTX
$2.35B
| $741K | ﹤0.01% |
8,913
-495
| -5% | -$39.2K |
|
1781
CALL
iShares MSCI South Korea ETF
EWY
$21.5B
| $740K | ﹤0.01% |
11,200
-248,800
| -96% | -$16M |
|
|
FREE
1782
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
| $737K | ﹤0.01% |
+151,669
| New | +$731K |
|
1783
Crane NXT
CXT
$3.1B
| $737K | ﹤0.01% |
+12,000
| New | +$735K |
|
|
IGMS
1784
DELISTED
IGM Biosciences
IGMS
| $737K | ﹤0.01% |
107,267
+36,491
| +52% | +$312K |
|
1785
PACS Group
PACS
$7.4B
| $733K | ﹤0.01% |
+24,854
| New | +$677K |
|
1786
Coherus Oncology
CHRS
$224M
| $727K | ﹤0.01% |
420,326
+268,763
| +177% | +$541K |
|
1787
United States Lime & Minerals
USLM
$3.4B
| $725K | ﹤0.01% |
+9,950
| New | +$663K |
|
1788
Miller Industries
MLR
$583M
| $721K | ﹤0.01% |
+13,107
| New | +$720K |
|
1789
Applied Digital
APLD
$7.64B
| $720K | ﹤0.01% |
+121,062
| New | +$470K |
|
1790
UroGen Pharma
URGN
$2.02B
| $719K | ﹤0.01% |
+42,841
| New | +$609K |
|
1791
RCM Technologies
RCMT
$203M
| $719K | ﹤0.01% |
38,392
+24,380
| +174% | +$484K |
|
1792
iShares ESG Aware MSCI EM ETF
ESGE
$6.44B
| $708K | ﹤0.01% |
21,102
-16
| -0.1% | -$527 |
|
1793
Oppenheimer Holdings
OPY
$1.2B
| $706K | ﹤0.01% |
14,736
+8,623
| +141% | +$368K |
|
1794
Anika Therapeutics
ANIK
$203M
| $705K | ﹤0.01% |
27,814
-6,478
| -19% | -$168K |
|
|
NFGC
1795
New Found Gold
NFGC
$545M
| $703K | ﹤0.01% |
+248,394
| New | +$875K |
|
1796
Mirum Pharmaceuticals
MIRM
$6.89B
| $702K | ﹤0.01% |
20,520
+5,420
| +36% | +$142K |
|
|
SVCO
1797
Silvaco Group
SVCO
$256M
| $699K | ﹤0.01% |
+38,900
| New | +$708K |
|
|
ASBPW
1798
CALL
Aspire Biopharma Warrant
ASBPW
$579K
| $699K | ﹤0.01% |
62,081
| – | – |
|
1799
Lyft
LYFT
$5.79B
| $697K | ﹤0.01% |
49,400
-1,227,760
| -96% | -$19.9M |
|
1800
Stepan Co
SCL
$1.32B
| $696K | ﹤0.01% |
+8,295
| New | +$709K |
|
Similar funds
Marshall Wace's Q2 2024 Portfolio in Review
As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.
- Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
- Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
- Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
- Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
- Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.
Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.